Joseph J. Larosa, EVP General Counsel and Secret at REGENERON PHARMACEUTICALS, INC. (REGN), sold 3,495 shares at $567.30 ($2.0M) on 2020-04-20, disclosed to the SEC on 2020-04-20.
Open-market sale of $2.0M REGN by EVP General Counsel and Secret. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $567.30 | 669 | $380K | 19.0% |
| 2 | $567.30 | 669 | $380K | 19.0% |
| 3 | $569.41 | 234 | $133K | 6.7% |
| 4 | $569.41 | 234 | $133K | 6.7% |
| 5 | $570.27 | 125 | $71K | 3.6% |
| 6 | $570.27 | 125 |
| $71K |
| 3.6% |
| 7 | $571.65 | 112 | $64K | 3.2% |
| 8 | $571.65 | 112 | $64K | 3.2% |
| 9 | $572.94 | 61 | $35K | 1.8% |
| 10 | $573.59 | 577 | $331K | 16.6% |
| 11 | $573.59 | 577 | $331K | 16.6% |
| Total | $570.25 avg | 3,495 | $2.0M | 100% |
| Filing → |
| REGN | SELL | 2024-02-28 | $990K | — | Filing → |
| REGN | SELL | 2024-02-26 | $968K | — | Filing → |
| REGN | SELL | 2024-02-09 | $950K | — | Filing → |